AffyImmune Therapeutics (“Affy”), a clinical stage biotechnology company focused on developing technologies that expand the utility and improve the safety and efficacy of cell-based immunotherapy for cancer, is seeking a Scientist to help advance the use of CAR T therapy for solid tumors. As part of the non-clinical team, you will [...]
AffyImmune Therapeutics (“Affy”), a development stage biotechnology company focused on creating technologies that expand the utility and improve the safety of cell-based immunotherapy for cancer, is seeking a Research Associate to perform experiments, organize and analyze results, and communicate effectively. As a Research Associate, you will join a small team at [...]
June 29, 2020 – AffyImmune Therapeutics, Inc. disclosed novel advancements in their proprietary affinity-tuned CAR T-cell programs and technology in three presentations at the recent Annual Meeting of the American Association for Cancer Research (AACR). One presentation reported on a new CAR T design for localized and inducible cytokine release. The [...]